Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories

L Leslie R. Zwerwer T Tim E. A. Peto K Koen B. Pouwels A Ann Sarah Walker D David W. Eyre N Nicole Stroesser P Philippa C. Matthews J Jia Wei (State Key Laboratory of Microbial Technology, Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal University) I Ian Diamond R Ruth Studley N Nick Taylor E Emma Rourke T Tina Thomas D Dawid Pienaar J Joy Preece S Sarah Crofts L Lina Lloyd M Michelle Bowen D Daniel Ayoubkhani R Russell Black A Antonio Felton M Megan Crees J Joel Jones E Esther Sutherland D Derrick W. Crook E Emma Pritchard K Karina-Doris Vihta A Alison Howarth B Brian D. Marsden K Kevin K. Chau L Lucas Martins Ferreira W Wanwisa Dejnirattisai J Juthathip Mongkolsapaya S Sarah Hoosdally R Richard Cornall D David I. Stuart (Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford) G Gavin Screaton K Katrina Lythgoe D David Bonsall T Tanya Golubchik H Helen Fryer J John N. Newton J John I. Bell S Stuart Cox K Kevin Paddon T Tim James T Thomas House J Julie Robotham P Paul Birrell H Helena Jordan T Tim Sheppard G Graham Athey D Dan Moody L Leigh Curry P Pamela Brereton I Ian Jarvis A Anna Godsmark G George Morris B Bobby Mallick P Phil Eeles J Jodie Hay H Harper VanSteenhouse J Jessica Lee S Sean White T Tim Evans L Lisa Bloemberg K Katie Allison A Anouska Pandya S Sophie Davis D David I. Conway (School of Medicine, Dentistry, and Nursing University of Glasgow Glasgow UK) M Margaret MacLeod C Chris Cunningham

Abstract

Abstract During the COVID-19 pandemic, numerous SARS-CoV-2 infections remained undetected. We combined results from routine monthly nose and throat swabs, and self-reported positive swab tests, from a UK household survey, linked to national swab testing programme data from England and Wales, together with Nucleocapsid (N-)antibody trajectories clustered using a longitudinal variation of K-means (N = 185,646) to estimate the number of infections undetected by either approach. Using N-antibody (hypothetical) infections and swab-positivity, we estimated that 7.4% (95%CI: 7.0–7.8%) of all true infections (detected and undetected) were undetected by both approaches, 25.8% (25.5–26.1%) by swab-positivity-only and 28.6% (28.4–28.9%) by trajectory-based N-antibody-classifications-only. Congruence with swab-positivity was respectively much poorer and slightly better with N-antibody classifications based on fixed thresholds or fourfold increases. Using multivariable logistic regression N-antibody seroconversion was more likely as age increased between 30–60 years, in non-white participants, those less (recently/frequently) vaccinated, for lower cycle threshold values in the range above 30, and in symptomatic and Delta (vs. BA.1) infections. Comparing swab-positivity data sources showed that routine monthly swabs were insufficient to detect infections and incorporating national testing programme/self-reported data substantially increased detection. Overall, whilst N-antibody serosurveillance can identify infections undetected by swab-positivity, optimal use requires fourfold-increase-based or trajectory-based analysis.

Article Details

Volume / Issue Vol. 16, Issue 1
Published May 14, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (72)

L

Leslie R. Zwerwer

T

Tim E. A. Peto

K

Koen B. Pouwels

A

Ann Sarah Walker

D

David W. Eyre

N

Nicole Stroesser

P

Philippa C. Matthews

J

Jia Wei

State Key Laboratory of Microbial Technology, Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal University

I

Ian Diamond

R

Ruth Studley

N

Nick Taylor

E

Emma Rourke

T

Tina Thomas

D

Dawid Pienaar

J

Joy Preece

S

Sarah Crofts

L

Lina Lloyd

M

Michelle Bowen

D

Daniel Ayoubkhani

R

Russell Black

A

Antonio Felton

M

Megan Crees

J

Joel Jones

E

Esther Sutherland

D

Derrick W. Crook

E

Emma Pritchard

K

Karina-Doris Vihta

A

Alison Howarth

B

Brian D. Marsden

K

Kevin K. Chau

L

Lucas Martins Ferreira

W

Wanwisa Dejnirattisai

J

Juthathip Mongkolsapaya

S

Sarah Hoosdally

R

Richard Cornall

D

David I. Stuart

Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford

G

Gavin Screaton

K

Katrina Lythgoe

D

David Bonsall

T

Tanya Golubchik

H

Helen Fryer

J

John N. Newton

J

John I. Bell

S

Stuart Cox

K

Kevin Paddon

T

Tim James

T

Thomas House

J

Julie Robotham

P

Paul Birrell

H

Helena Jordan

T

Tim Sheppard

G

Graham Athey

D

Dan Moody

L

Leigh Curry

P

Pamela Brereton

I

Ian Jarvis

A

Anna Godsmark

G

George Morris

B

Bobby Mallick

P

Phil Eeles

J

Jodie Hay

H

Harper VanSteenhouse

J

Jessica Lee

S

Sean White

T

Tim Evans

L

Lisa Bloemberg

K

Katie Allison

A

Anouska Pandya

S

Sophie Davis

D

David I. Conway

School of Medicine, Dentistry, and Nursing University of Glasgow Glasgow UK

M

Margaret MacLeod

C

Chris Cunningham